ArticleJournal of molecular medicine (Berlin, Germany)2022
Transcription factor EB inhibits non-alcoholic fatty liver disease through fibroblast growth factor 21.
Qi Gong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it